GlobeNewswire by notified

Aduro to Exhibit and Present at Oil Sands Conference and Trade Show

Share

SARNIA, Ontario, Aug. 25, 2022 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. (CSE: ACT) (OTCQB: ACTHF) (FSE: 9D50) (the “Company” or “Aduro Clean Technologies”), a developer of patented water-based technologies to chemically recycle plastics and transform heavy crude and renewable oils into new-era resources and higher-value fuels, announces that Abe Dyck, VP Strategy & Business Development, will be a featured speaker at the Oil Sands Conference & Trade Show which is taking place in Fort McMurray, Alberta on September 14th & 15th, 2022. The Company will also be exhibiting at booth 3323 in Exhibit Hall C.

To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.

The Oil Sands Conference & Trade Show (OSCTS) is a premier event specifically developed for Alberta’s oil sands sector. This event features a large-scale exhibition, two-day business conference, two days of technical presentations, as well as a number of high-impact networking functions. The show and conference focus on promoting the latest technologies, maintenance, shutdowns/turnarounds, mining, upgrading, health and safety, and environment strategies in the energy industry. It is the leading industry-specific event for oil sands operators and their contractors to seek solutions and innovations to reduce costs and maximize existing equipment and facilities.

Abe Dyck, VP Strategy & Business Development, will join the TECHTalks Series and present “Hydrochemolysis: An Innovative And Highly Effective Methodology For Heavy Oil Upgrading And Plastics Upcycling”. Participating in this event enables Aduro to meet directly with industry partners and operators.

About Aduro Clean Technologies
Aduro Clean Technologies is a developer of patented water-based technologies to chemically recycle waste plastics; convert heavy crude and bitumen into lighter, more valuable oil; and transform renewable oils into higher-value fuels or renewable chemicals. The Company’s Hydrochemolytic™ technology activates unique properties of water in a chemistry platform that operates at relatively low temperatures and cost – a game-changing approach that converts low-value feedstocks into 21st-century resources. With funding and support from Bioindustrial Innovation Canada, the Company has developed a pre-pilot reactor system to upgrade heavy petroleum into lighter oil.

For further information, please contact:

Ofer Vicus, CEO
ovicus@adurocleantech.com

Abe Dyck, Investor Relations
ir@adurocleantech.com
+1 604-362-7011

Investor Cubed Inc.
Neil Simon, CEO
nsimon@investor3.ca
+ 1 647 258 3310

Forward-Looking Statements

This news release contains forward-looking statements. All statements, other than statements of historical fact that address activities, events, or developments that the Company believes, expects or anticipates will or may occur in the future, are forward-looking statements. The forward-looking statements reflect management’s current expectations based on information currently available and are subject to a number of risks and uncertainties that may cause outcomes to differ materially from those discussed in the forward-looking statements. Although the Company believes that the assumptions inherent in the forward-looking statements are reasonable, forward-looking statements are not guarantees of future performance and, accordingly, undue reliance should not be put on such statements due to their inherent uncertainty. Important factors that could cause actual results to differ materially from the Company’s expectations include adverse market conditions and other factors beyond the control of the parties. The Company expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by applicable law.

The CSE has not reviewed, approved, or disapproved the content of this news release.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/52eac15e-c417-46eb-9afe-736e9315efc4

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Iveco Group: periodic report on the buyback program4.12.2023 17:50:00 CET | Press release

Turin, 4th December 2023. Iveco Group N.V. (EXM: IVG) announces that, under the ongoing initial tranche of the common share buyback program announced on 14th April 2023, the Company completed on a daily basis, starting from 27th November 2023 to 1st December 2023 the following transactions: DateNumber of repurchased Common SharesAverage net price (euro)Total net consideration (euro)27 November 202337,8007.2557274,266.1228 November 202338,3007.3074279,872.2029 November 202337,3007.4251276,956.9630 November 202336,9007.4309274,201.681 December 202336,6007.5204275,245.06Total186,9007.38651,380,542.03 An overall overview of the purchases carried out under the current share buyback program as well as the details of the above transactions, are available on the Company’s corporate website at the following address: https://www.ivecogroup.com/investors/stock_information/share_buyback. Iveco Group N.V. (EXM: IVG) is the home of unique people and brands that power your business and mission to adv

Innofactor Plc: Share Repurchase 4.12.20234.12.2023 17:30:00 CET | Press release

Innofactor Plc Announcement 4.12.2023Innofactor Plc: Share Repurchase 4.12.2023In the Helsinki Stock ExchangeTrade date 4.12.2023Bourse trade BuyShare IFA1VAmount 4,700SharesAverage price/ share 1.1600EURTotal cost 5,452.00EURInnofactor Plc now holds a total of 566 529 sharesincluding the shares repurchased on 4.12.2023On behalf of Innofactor PlcNordea Bank OyjJanne Sarvikivi Sami HuttunenAdditional information:Sami Ensio, CEOInnofactor PlcTel. +358 50 584 2029sami.ensio@innofactor.comwww.innofactor.com Attachment Innofactor_4.12_trades

Borregaard ASA: Share buy-back programme completed4.12.2023 16:58:26 CET | Press release

04.12.2023: Borregaard ASA (”Borregaard”, OSE ticker: BRG) Reference is made to the stock exchange notice of 17 November 2023 where Borregaard announced the intent to repurchase up to 200,000 of its outstanding common stock. The repurchase of shares will be conducted in a period from 20th November up to and including 20th December 2023 at the latest. Borregaard has in the period from 29 November up to and including 4 December in total purchased 60,204 own shares through broker at an average price of NOK 173.24 per share. By these transactions, Borregaard has completed its share buy-back programme by repurchasing 200,000 shares of its outstanding common stock. Aggregated overview of transactions per day: DateAggregated daily volume (number of shares)Weighted average share price per day (NOK)Total daily transaction value (NOK)29.11.20239,142173.32161,584,506.0730.11.202317,258172.80752,982,311.8401.12.202316,902172.73082,919,495.9804.12.202316,902174.14862,943,459.64Previously disclosed

BBS-Bioactive Bone Substitutes Plc: Managers' Transactions - Pekka Jalovaara4.12.2023 15:45:00 CET | Press release

BBS-Bioactive Bone Substitutes Plc, Company announcement, Management transactions, 4 December 2023 at 4.45 p.m. (EET) BBS-Bioactive Bone Substitutes Oyj - Managers' Transactions – Pekka Jalovaara ____________________________________________ Person subject to the notification requirement Name: Jalovaara Pekka Position: Member of the Board/Deputy member Issuer: BBS Bioactive Bone Substitutes Oyj LEI: 743700BYSBP0PCR6N767 Notification type: INITIAL NOTIFICATION Reference number: 743700BYSBP0PCR6N767_20231203205051_6 ____________________________________________ Transaction date: 2023-11-30 Venue not applicable Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT ISIN: FI4000260583 Nature of the transaction: DISPOSAL Transaction details (1): Volume: 126,606 Unit price: 0.005012 EUR Aggregated transactions (1): Volume: 126,606 Volume weighted average price: 0.005012 EUR ____________________________________________ Person subject to the notification requirement Name: J